Head-To-Head Survey: Schrodinger (NASDAQ:SDGR) vs. Health In Tech (NASDAQ:HIT)

Schrodinger (NASDAQ:SDGR) and Health In Tech (NASDAQ:HIT) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings.

Profitability

This table compares Schrodinger and Health In Tech’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Schrodinger	-22.02%	-17.66%	-8.89%
Health In Tech	N/A	N/A	N/A

Insider and Institutional Ownership

79.0% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 71.0% of Health In Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Schrodinger and Health In Tech”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87 million	8.30	-$103.26 million	($0.79)	-36.42
Health In Tech	$32.83 million	1.15	-$4.59 million	($0.07)	-8.23

Health In Tech has lower revenue, but higher earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, Health In Tech has a beta of 3.02, meaning that its share price is 202% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings for Schrodinger and Health In Tech, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1	3	4	0	2.38
Health In Tech	1	0	1	1	2.67

Schrodinger presently has a consensus price target of $26.67, suggesting a potential downside of 7.31%. Health In Tech has a consensus price target of $3.50, suggesting a potential upside of 507.22%. Given Health In Tech’s stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than Schrodinger.

Summary

Health In Tech beats Schrodinger on 11 of the 15 factors compared between the two stocks.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.